19-10092270-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018381.4(SHFL):c.844G>A(p.Val282Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,599,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018381.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SHFL | NM_018381.4 | c.844G>A | p.Val282Met | missense_variant | 8/8 | ENST00000253110.16 | |
SHFL | NM_001308277.2 | c.736G>A | p.Val246Met | missense_variant | 8/8 | ||
SHFL | XM_047439046.1 | c.727G>A | p.Val243Met | missense_variant | 7/7 | ||
SHFL | XM_047439047.1 | c.691G>A | p.Val231Met | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SHFL | ENST00000253110.16 | c.844G>A | p.Val282Met | missense_variant | 8/8 | 2 | NM_018381.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000273 AC: 6AN: 219812Hom.: 0 AF XY: 0.0000335 AC XY: 4AN XY: 119292
GnomAD4 exome AF: 0.0000111 AC: 16AN: 1447616Hom.: 0 Cov.: 32 AF XY: 0.0000125 AC XY: 9AN XY: 719130
GnomAD4 genome AF: 0.000171 AC: 26AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.844G>A (p.V282M) alteration is located in exon 8 (coding exon 8) of the C19orf66 gene. This alteration results from a G to A substitution at nucleotide position 844, causing the valine (V) at amino acid position 282 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at